A clinical trial to study effectiveness and safety of Revaprazan tablets in comparison with Omeprazole capsules in patients suffering from Peptic Ulcer or Acute Gastritis
Phase 3
Completed
- Conditions
- Health Condition 1: K297- Gastritis, unspecifiedHealth Condition 2: null- Peptic ulcer & Acute gastritisHealth Condition 3: K279- Peptic ulcer, site unspecified, unspecified as acute or chronic, without hemorrhage or perforation
- Registration Number
- CTRI/2010/091/001055
- Lead Sponsor
- Cadila Healthcare Ltd
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 200
Inclusion Criteria
1.Patients of either sex of 19 to 75 years of age.
2.Established diagnosis of peptic ulcer or acute gastritis.
3.Informed consent of the patient/relative.
Exclusion Criteria
1.Pregnancy or Lactation.
2.Clinically significant disorder of liver, kidney, cardiovascular system, respiratory system, endocrine system and CNS.
3.Not eligible to undergo endoscopy.
4.Zollinger-Ellison syndrome.
5.Patients requiring use of any unacceptable concomitant medications
6.Patients with any other serious concurrent illness or malignancy.
7.Patients with continuing history of alcohol and / or drug abuse.
8.Participation in another clinical trial in the past 3 months.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method